5 research outputs found
Preoperative Cerebrospinal Fluid Cortisol and the Risk of Postoperative Delirium: A Prospective Study of Older Hip Fracture Patients
Background: Ageing, depression, and neurodegenerative disease are common risk factors for delirium in the elderly. These risk factors are associated with dysregulation of the hypothalamic-pituitary-adrenal axis, resulting in higher levels of cortisol under normal and stressed conditions and a slower return to baseline. Objectives: We investigated whether elevated preoperative cerebrospinal fluid (CSF) cortisol levels are associated with the onset of postoperative delirium. Methods: In a prospective cohort study CSF samples were collected after cannulation for the introduction of spinal anesthesia of 75 patients aged 75 years and older admitted for surgical repair of acute hip fracture. Delirium was assessed with the confusion assessment method (CAM) and the Delirium Rating Scale-Revised-98 (DRS-R98). Because the CAM and DRS-R98 were available for time of admission and 5 postoperative days, we used generalized estimating equations and linear mixed modeling to examine the association between preoperative CSF cortisol levels and the onset of postoperative delirium. Results: Mean age was 83.5 (SD 5.06) years, and prefracture cognitive decline was present in one-third of the patients (24 [33%]). Postoperative delirium developed in 27 (36%) patients. We found no association between preoperative CSF cortisol levels and onset or severity of postoperative delirium. Conclusions: These findings do not support the hypothesis that higher preoperative CSF cortisol levels are associated with the onset of postoperative delirium in elderly hip fracture patients
The neuropsychological sequelae of delirium in elderly patients with hip fracture three months after hospital discharge
Clinical study predicting delirium duration in elderly hip-surgery patients: does early symptom profile matter?
Background. Features thatmay allow early identification of patients at risk of prolonged delirium, and therefore of poorer outcomes,
are not well understood.The aim of this study was to determine if preoperative delirium risk factors and delirium symptoms (at
onset and clinical symptomatology during the course of delirium) are associated with delirium duration. Methods. This study was
conducted in prospectively identified cases of incident delirium.We compared patients experiencing delirium of short duration (1
or 2 days) with patients who had more prolonged delirium (≥3 days) with regard to DRS-R-98 (Delirium Rating Scale Revised-
98) symptoms on the first delirious day. Delirium symptom profile was evaluated daily during the delirium course. Results. In a
homogenous population of 51 elderly hip-surgery patients, we found that the severity of individual delirium symptoms on the first
day of deliriumwas not associated with duration of delirium. Preexisting cognitive decline was associated with prolonged delirium.
Longitudinal analysis using the generalised estimating equations method (GEE) identified that more severe impairment of longtermmemory
across the whole deliriumepisode was associated with longer duration of delirium. Conclusion. Preexisting cognitive
decline rather than severity of individual delirium symptoms at onset is strongly associated with delirium duration
Predicting delirium duration in elderly hip-surgery patients: does early symptom profile matter?
Background. Features thatmay allow early identification of patients at risk of prolonged delirium, and therefore of poorer outcomes,
are not well understood.The aim of this study was to determine if preoperative delirium risk factors and delirium symptoms (at
onset and clinical symptomatology during the course of delirium) are associated with delirium duration. Methods. This study was
conducted in prospectively identified cases of incident delirium.We compared patients experiencing delirium of short duration (1
or 2 days) with patients who had more prolonged delirium (≥3 days) with regard to DRS-R-98 (Delirium Rating Scale Revised-
98) symptoms on the first delirious day. Delirium symptom profile was evaluated daily during the delirium course. Results. In a
homogenous population of 51 elderly hip-surgery patients, we found that the severity of individual delirium symptoms on the first
day of deliriumwas not associated with duration of delirium. Preexisting cognitive decline was associated with prolonged delirium.
Longitudinal analysis using the generalised estimating equations method (GEE) identified that more severe impairment of longtermmemory
across the whole deliriumepisode was associated with longer duration of delirium. Conclusion. Preexisting cognitive
decline rather than severity of individual delirium symptoms at onset is strongly associated with delirium duration
Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial
Background Treatment of patients with ileocaecal Crohn's disease who have not responded to conventional therapy is commonly scaled up to biological agents, but surgery can also offer excellent short-term and long-term results. We compared laparoscopic ileocaecal resection with infliximab to assess how they affect health-related quality of life. Methods In this randomised controlled, open-label trial, in 29 teaching hospitals and tertiary care centres in the Netherlands and the UK, adults with non-stricturing, ileocaecal Crohn's disease, in whom conventional therapy has failed were randomly allocated (1:1) by an internet randomisation module with biased-coin minimisation for participating centres and perianal fistula to receive laparoscopic ileocaecal resection or infliximab. Eligible patients were aged 18–80 years, had active Crohn's disease of the terminal ileum, and had not responded to at least 3 months of conventional therapy with glucocorticosteroids, thiopurines, or methotrexate. Patients with diseased terminal ileum longer than 40 cm or abdominal abscesses were excluded. The primary outcome was quality of life on the Inflammatory Bowel Disease Questionnaire (IBDQ) at 12 months. Secondary outcomes were general quality of life, measured by the Short Form-36 (SF-36) health survey and its physical and mental component subscales, days unable to participate in social life, days on sick leave, morbidity (additional procedures and hospital admissions), and body image and cosmesis. Analyses of the primary outcome were done in the intention-to-treat population, and safety analyses were done in the per-protocol population. This trial is registered at the Dutch Trial Registry (NTR1150). Findings Between May 2, 2008, and October 14, 2015, 73 patients were allocated to have resection and 70 to receive infliximab. Corrected for baseline differences, the mean IBDQ score at 12 months was 178·1 (95% CI 171·1–185·0) in the resection group versus 172·0 (164·3–179·6) in the infliximab group (mean difference 6·1 points, 95% CI −4·2 to 16·4; p=0·25). At 12 months, the mean SF-36 total score was 112·1 (95% CI 108·0–116·2) in the resection group versus 106·5 (102·1–110·9) in the infliximab group (mean difference 5·6, 95% CI −0·4 to 11·6), the mean physical component score was 47·7 (45·7–49·7) versus 44·6 (42·5–46·8; mean difference 3·1, 4·2 to 6·0), and the mean mental component score was 49·5 (47·0–52·1) versus 46·1 (43·3–48·9; mean difference 3·5, −0·3 to 7·3). Mean numbers of days of sick leave were 3·4 days (SD 7·1) in the resection group versus 1·4 days (4·7) in the infliximab group (p<0·0001), days not able to take part in social life were 1·8 days (6·3) versus 1·1 days (4·5; p=0·20), days of scheduled hospital admission were 6·5 days (3·8) versus 6·8 days (3·2; p=0·84), and the number of patients who had unscheduled hospital admissions were 13 (18%) of 73 versus 15 (21%) of 70 (p=0·68). Body-image scale mean scores in the patients who had resection were 16·0 (95% CI 15·2–16·8) at baseline versus 17·8 (17·1–18·4) at 12 months, and cosmetic scale mean scores were 17·6 (16·6–18·6) versus 18·6 (17·6–19·6). Surgical intervention-related complications classified as IIIa or worse on the Clavien-Dindo scale occurred in four patients in the resection group. Treatment-related serious adverse events occurred in two patients in the infliximab group. During a median follow-up of 4 years (IQR 2–6), 26 (37%) of 70 patients in the infliximab group had resection, and 19 (26%) of 73 patients in the resection group received anti-TNF. Interpretation Laparoscopic resection in patients with limited (diseased terminal ileum <40 cm), non-stricturing, ileocaecal Crohn's disease in whom conventional therapy has failed could be considered a reasonable alternative to infliximab therapy. Funding Netherlands Organisation for Health Research and Development